[Ip-health] Guardian on Health Impact Fund

[Aidan Hollis]

Peter Singer (Princeton) has an article in the Guardian on the Health Impact
Fund:

http://www.guardian.co.uk/commentisfree/2008/sep/16/health.pharmaceuticals

...
"The beauty of the scheme is that it gives economic support to the idea that
all human lives are of equal value. For products that drug companies
register with the health impact fund, corporations would get the same reward
for saving the lives of Africans living in extreme poverty as they would get
for saving the lives of wealthy citizens of affluent nations.

The most potentially lucrative targets would become the diseases that kill
the most people, because that is where a breakthrough drug would have the
biggest impact on global health. Moreover, companies would have an incentive
to produce and distribute drugs at the lowest possible price, because only
when the poor could use them would the drug save the greatest possible
number of lives."

...

Aidan Hollis

Associate Professor
Department of Economics, University of Calgary
2500 University Dr NW Calgary AB T2N 1N4 Canada

tel: +1 403 220 5861  fax: +1 403 220 5861
email: ahollis@ucalgary.ca
web: http://econ.ucalgary.ca/profiles/aidan-michael-hollis

Incentives for Global Health
http://www.healthimpactfund.org